82 related articles for article (PubMed ID: 9558070)
21. Unexpected reactivities of T cells selected by a single MHC-peptide ligand.
Singh N; Van Kaer L
J Immunol; 1999 Oct; 163(7):3583-91. PubMed ID: 10490950
[TBL] [Abstract][Full Text] [Related]
22. Modification of peptide interaction with MHC creates TCR partial agonists.
Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
[TBL] [Abstract][Full Text] [Related]
23. The differentiated state of intestinal lamina propria CD4+ T cells results in altered cytokine production, activation threshold, and costimulatory requirements.
Hurst SD; Cooper CJ; Sitterding SM; Choi Jh; Jump RL; Levine AD; Barrett TA
J Immunol; 1999 Dec; 163(11):5937-45. PubMed ID: 10570280
[TBL] [Abstract][Full Text] [Related]
24. CD4+ T cell responses to CD40-deficient APCs: defects in proliferation and negative selection apply only with B cells as APCs.
Ozaki ME; Coren BA; Huynh TN; Redondo DJ; Kikutani H; Webb SR
J Immunol; 1999 Nov; 163(10):5250-6. PubMed ID: 10553046
[TBL] [Abstract][Full Text] [Related]
25. The CD8 beta polypeptide is required for the recognition of an altered peptide ligand as an agonist.
Renard V; Delon J; Luescher IF; Malissen B; Vivier E; Trautmann A
Eur J Immunol; 1996 Dec; 26(12):2999-3007. PubMed ID: 8977296
[TBL] [Abstract][Full Text] [Related]
26. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
Kleindienst P; Brocker T
Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
[TBL] [Abstract][Full Text] [Related]
27. Antigen presentation by T cells inhibits IL-2 production and induces IL-4 release due to altered cognate signals.
Lombardi G; Hargreaves R; Sidhu S; Imami N; Lightstone L; Fuller-Espie S; Ritter M; Robinson P; Tarnok A; Lechler R
J Immunol; 1996 Apr; 156(8):2769-75. PubMed ID: 8609395
[TBL] [Abstract][Full Text] [Related]
28. The T lymphocyte response to cytochrome c. IV. Distinguishable sites on a peptide antigen which affect antigenic strength and memory.
Hansburg D; Fairwell T; Schwartz RH; Appella E
J Immunol; 1983 Jul; 131(1):319-24. PubMed ID: 6190913
[TBL] [Abstract][Full Text] [Related]
29. Lead enhances CD4+ T cell proliferation indirectly by targeting antigen presenting cells and modulating antigen-specific interactions.
Farrer DG; Hueber SM; McCabe MJ
Toxicol Appl Pharmacol; 2005 Sep; 207(2):125-37. PubMed ID: 15885731
[TBL] [Abstract][Full Text] [Related]
30. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
Schweitzer AN; Sharpe AH
J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
[TBL] [Abstract][Full Text] [Related]
31. Basophils can directly present or cross-present antigen to CD8 lymphocytes and alter CD8 T cell differentiation into IL-10-producing phenotypes.
Kim S; Shen T; Min B
J Immunol; 2009 Sep; 183(5):3033-9. PubMed ID: 19667092
[TBL] [Abstract][Full Text] [Related]
32. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
Sepulveda H; Cerwenka A; Morgan T; Dutton RW
J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
[TBL] [Abstract][Full Text] [Related]
33. Freshly isolated Langerhans cells negatively regulate naïve T cell activation in response to peptide antigen through cell-to-cell contact.
Imai Y; Hayashi N; Yasuda K; Tsutsui H; Mizutani H; Nakanishi K
J Dermatol Sci; 2008 Jul; 51(1):19-29. PubMed ID: 18367382
[TBL] [Abstract][Full Text] [Related]
34. An antagonist peptide mediates positive selection and CD4 lineage commitment of MHC class II-restricted T cells in the absence of CD4.
Kao H; Allen PM
J Exp Med; 2005 Jan; 201(1):149-58. PubMed ID: 15630142
[TBL] [Abstract][Full Text] [Related]
35. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
Mejri N; Brossard M
Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
[TBL] [Abstract][Full Text] [Related]
36. Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation.
McNeil LK; Evavold BD
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4520-5. PubMed ID: 11904393
[TBL] [Abstract][Full Text] [Related]
37. IL-1 acts on antigen-presenting cells to enhance the in vivo proliferation of antigen-stimulated naive CD4 T cells via a CD28-dependent mechanism that does not involve increased expression of CD28 ligands.
Khoruts A; Osness RE; Jenkins MK
Eur J Immunol; 2004 Apr; 34(4):1085-90. PubMed ID: 15048719
[TBL] [Abstract][Full Text] [Related]
38. Serial TCR engagement and down-modulation by peptide:MHC molecule ligands: relationship to the quality of individual TCR signaling events.
Itoh Y; Hemmer B; Martin R; Germain RN
J Immunol; 1999 Feb; 162(4):2073-80. PubMed ID: 9973480
[TBL] [Abstract][Full Text] [Related]
39. The T lymphocyte response to cytochrome c. V. Determination of the minimal peptide size required for stimulation of T cell clones and assessment of the contribution of each residue beyond this size to antigenic potency.
Schwartz RH; Fox BS; Fraga E; Chen C; Singh B
J Immunol; 1985 Oct; 135(4):2598-608. PubMed ID: 2411804
[TBL] [Abstract][Full Text] [Related]
40. Development of CD25(+) T cells secreting transforming growth factor-beta1 by altered peptide ligands expressed as self-antigens.
Yamashiro H; Hozumi N; Nakano N
Int Immunol; 2002 Aug; 14(8):857-65. PubMed ID: 12147622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
